Merck Manual

Please confirm that you are not located inside the Russian Federation

honeypot link

Idiopathic Pleuroparenchymal Fibroelastosis

By

Joyce Lee

, MD, MAS, University of Colorado Denver

Last full review/revision Jun 2021| Content last modified Jun 2021
Click here for the Professional Version

Idiopathic pleuroparenchymal fibroelastosis is a rare idiopathic interstitial pneumonia that is slowly progressive.

  • People often have recurrent infections, shortness of breath, and a dry cough.

  • Doctors use computed tomography and sometimes lung biopsy to diagnose the disease.

  • Treatment usually involves giving corticosteroids.

Idiopathic pleuroparenchymal fibroelastosis is a rare condition that is classified as an idiopathic interstitial pneumonia.

Idiopathic means the cause is unknown, but experts think the disorder may be related to recurrent lung infections. However, genetic and autoimmune factors may also play a role in idiopathic pleuroparenchymal fibroelastosis.

Men and women are affected about evenly. Idiopathic pleuroparenchymal fibroelastosis occurs in people of all ages. However, the median age when the disease starts is around 57 years. Most affected people are nonsmokers.

People may have recurrent infections, shortness of breath, and a dry cough. Pneumothorax is common during the course of the disease.

Diagnosis of idiopathic pleuroparenchymal fibroelastosis requires chest computed tomography (CT). Sometimes a biopsy of the lung is needed to confirm the diagnosis.

The appropriate treatment for this condition is unknown. Sometimes doctors give corticosteroids because they are effective in some of the other idiopathic interstitial pneumonias, but their effectiveness in idiopathic pleuroparenchymal fibroelastosis is unknown.

NOTE: This is the Consumer Version. DOCTORS: Click here for the Professional Version
Click here for the Professional Version
Others also read

Test your knowledge

Overview of Environmental Lung Diseases
Environmental lung diseases are caused by harmful particles, mists, vapors, or gases that are inhaled, usually while people work. Which of the following factors determines where in the airways or lungs a harmful inhaled particle ends up? 
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
TOP